García del Muro, Xavier
Maurel, Joan
Martínez Trufero, Javier
Lavernia, Javier
López Pousa, Antonio
de las Peñas, Ramón
Cubedo, Ricardo
Berros, José Pablo
Casado Herráez, Antonio
de Juan, Ana
Martín Broto, Javier
Funding for this research was provided by:
Bayer HealthCare
Article History
Received: 17 January 2018
Accepted: 28 February 2018
First Online: 12 March 2018
Compliance with ethical standards
:
: Xavier García del Muro: XG has received research grants from Bayer and Astra Zeneca. XG has received a speaker honorarium from Pfizer, Lilly, Novartis, Ipsen and BMS.Javier Martín Broto: Consulting or Advisory Role from PharmaMar, GSK, Novartis, Amgen, Bayer, Lilly.Rest of the authors <i>declare that they have no conflict of interest.</i>
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: The authors have no relevant affiliations or financial involvements with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.